Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Doxorubicin × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 121 Lymphoma 84 Lymphoma, Large B-Cell, Diffuse 64 Sarcoma 52 Hodgkin Disease 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Burkitt Lymphoma 30 Triple Negative Breast Neoplasms 27 Lymphoma, Non-Hodgkin 23 Lymphoma, Mantle-Cell 23 Leukemia 22 Lymphoma, Follicular 21 Neoplasms 18 Neoplasm Metastasis 17 Neuroblastoma 15 Multiple Myeloma 15 Carcinoma, Hepatocellular 15 Ovarian Neoplasms 14 Lymphoma, B-Cell 13 Liver Neoplasms 11 Urinary Bladder Neoplasms 10 Prostatic Neoplasms 10 Osteosarcoma 10 Breast Neoplasms, Male 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large-Cell, Immunoblastic 9 Dendritic Cell Sarcoma, Interdigitating 9 Lymphoma, Large-Cell, Anaplastic 8 Inflammatory Breast Neoplasms 8 Leiomyosarcoma 7

Interventions

Fluorouracil 77 Leucovorin 70 Oxaliplatin 69 Irinotecan 67 Bevacizumab 43 Capecitabine 36 Cetuximab 33 Panitumumab 14 Folfox protocol 14 Floxuridine 10 Chemotherapy, Adjuvant 10 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 IFL protocol 8 Drug Therapy 8 regorafenib 7 pembrolizumab 7 Nivolumab 7 trifluridine tipiracil drug combination 6 XELOX 6 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 tislelizumab 4 Trifluridine 4 S 1 (combination) 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01464593 2022-10-13

ABLATE

Imunon

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡